CFD's zijn complexe instrumenten en gaan gepaard met een hoog risico snel kapitaal te verliezen als gevolg van hefboommechanismen. 77.3% an de retailbeleggers lijdt verlies op de handel in CFD's met deze aanbieder. U dient zorgvuldig te overwegen of u begrijpt hoe CFD's werken en of u het zich kunt veroorloven om hoge risico's te nemen op het verliezen van uw kapitaal.

Close

Handelen Novavax NVAX

Novavax live grafieken

instrument_fundamentals

Weekly Search
Weekly
Daily
Datum Sluit Verandering % verandering Openen Piek Bodem

Novavax news

2021 Mei 11, 13:20

US pre-market: selling unabated

2021 Mei 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 Mei 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Laatste marktnieuws

Toon meer
N/A
Noah Lee 2025 Jul 03, 08:35

Wall Street Strategist: Potential $100B+ Stock Market Influx Coming

N/A
Sophia Claire 2025 Jul 03, 08:35

Euro Surges in Foreign Exchange Options Market Amid Bullish Sentiment

N/A
Emma Rose 2025 Jul 03, 08:35

AI Podcast: The Pennsylvania Plan - Domestic Investors to the Rescue?

N/A
liam james 2025 Jul 03, 08:35

AI Podcast: Dollar Weakens Amid Fed Chair Uncertainty

N/A
liam james 2025 Jul 03, 08:35

JPMorgan Model Predicts Stock Market Upswing: An AI Podcast Breakdown

N/A
Ava Grace 2025 Jul 03, 08:35

Dollar Index Plummets Amid Fed Independence Concerns

N/A
liam james 2025 Jul 03, 07:35

AI Podcast: Decoding Economic Indicators and Fed Policy

N/A
Sophia Claire 2025 Jul 03, 07:35

AI Podcast: S&P 500 Hits Record High, Sparking Market Bubble Fears

Info

Spread

0.05

Spread (%)

0.7375 %

Hefboom

1:5

Dagrente kopen

-0.0597 %

Dagrente verkopen

-0.0292 %

Valuta

USD

Openingstijden

Markt openen

Donderdag

13:31 - 16:59

Maandag

13:31-19:59

Dinsdag

13:31-19:59

Woensdag

13:31-19:59

instr__analysis_statistics

Openen

---

Vorige Sluiten

---

52-weekse hoog/laag

--- – ---

Beurswaarde

1094917248

Uitstaande aandelen

161970000

Datum winstcijfer (volgende)

2019-05-10

Div. rend.

2019-05-10

Ex-dividenddatum

Jaarlijks verwachte dividendpercentage

0

Jaarlijks verwachte dividendrendement

0

Winst per aandeel

2.75

Meer informatie over dit instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Gerelateerde instrumenten

Activa
Verkoop
Koop
% verandering
Gerelateerde instrumenten

latest_education_articles

Toon meer
Trustpilot